Literature DB >> 7640221

Microsatellite instability in ovarian neoplasms.

B L King1, M L Carcangiu, D Carter, M Kiechle, J Pfisterer, A Pfleiderer, B M Kacinski.   

Abstract

Microsatellite instability has been observed in a variety of sporadic malignancies, but its existence in sporadic ovarian cancer has been the subject of conflicting reports. We have performed a polymerase chain reaction-based microsatellite analysis of DNAs extracted from the neoplastic and non-neoplastic tissues of 41 ovarian cancer patients. Tumour-associated alterations were observed in seven (17%) of these cases. Clinicopathological correlations revealed that: (1) alterations among tumours classified as serous adenocarcinomas occurred with relatively low frequency (2/24 or 8%); (2) most of the tumours with microsatellite alterations (5/7 or 71%) were of less common histopathological types (epithelial subtypes such as endometrioid and mixed serous and mucinous, or non-epithelial types such as malignant mixed Müllerian or germ cell tumours); (3) tumour-associated alterations were observed in 3/4 (75%) of the patients with stage I tumours vs 4/37 (11%) of the patients with stage II, III and IV tumours (P = 0.01); (4) tumour-associated microsatellite instability was found to occur with similar frequencies among patients with and without clinical features suggestive of familial disease, including positive family history, early onset, or multiple primary tumours. In summary, we have observed microsatellite alterations in the neoplastic tissues of ovarian cancer patients with diverse genetic backgrounds and clinicopathological features. The pattern of alterations is consistent with the possibility that multiple mechanisms may be responsible for microsatellite instability in ovarian neoplasms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7640221      PMCID: PMC2033989          DOI: 10.1038/bjc.1995.341

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  42 in total

1.  Genetic instability of microsatellite sequences in many non-small cell lung carcinomas.

Authors:  V Shridhar; J Siegfried; J Hunt; M del Mar Alonso; D I Smith
Journal:  Cancer Res       Date:  1994-04-15       Impact factor: 12.701

2.  A polymerase chain reaction-based microsatellite typing assay used for tumor cell line identification.

Authors:  B L King; A Lichtenstein; J Berenson; B M Kacinski
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

3.  Mutation of a mutL homolog in hereditary colon cancer.

Authors:  N Papadopoulos; N C Nicolaides; Y F Wei; S M Ruben; K C Carter; C A Rosen; W A Haseltine; R D Fleischmann; C M Fraser; M D Adams
Journal:  Science       Date:  1994-03-18       Impact factor: 47.728

4.  Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability.

Authors:  A Umar; J C Boyer; D C Thomas; D C Nguyen; J I Risinger; J Boyd; Y Ionov; M Perucho; T A Kunkel
Journal:  J Biol Chem       Date:  1994-05-20       Impact factor: 5.157

5.  Microsatellite instability occurs frequently in human gastric carcinoma.

Authors:  M G Rhyu; W S Park; S J Meltzer
Journal:  Oncogene       Date:  1994-01       Impact factor: 9.867

6.  Frequent microsatellite instability in primary small cell lung cancer.

Authors:  A Merlo; M Mabry; E Gabrielson; R Vollmer; S B Baylin; D Sidransky
Journal:  Cancer Res       Date:  1994-04-15       Impact factor: 12.701

7.  Instability of short tandem repeats (microsatellites) in human cancers.

Authors:  R Wooster; A M Cleton-Jansen; N Collins; J Mangion; R S Cornelis; C S Cooper; B A Gusterson; B A Ponder; A von Deimling; O D Wiestler
Journal:  Nat Genet       Date:  1994-02       Impact factor: 38.330

8.  Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer.

Authors:  H J Han; A Yanagisawa; Y Kato; J G Park; Y Nakamura
Journal:  Cancer Res       Date:  1993-11-01       Impact factor: 12.701

9.  Hypermutability and mismatch repair deficiency in RER+ tumor cells.

Authors:  R Parsons; G M Li; M J Longley; W H Fang; N Papadopoulos; J Jen; A de la Chapelle; K W Kinzler; B Vogelstein; P Modrich
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

10.  Polymerase chain reaction allelotyping of human ovarian cancer.

Authors:  R J Osborne; V Leech
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

View more
  20 in total

Review 1.  Molecular genetics of ovarian cancer.

Authors:  A N Shelling; W Foulkes
Journal:  Mol Biotechnol       Date:  2001-09       Impact factor: 2.695

Review 2.  Frequency of mismatch repair deficiency in ovarian cancer: a systematic review This article is a US Government work and, as such, is in the public domain of the United States of America.

Authors:  Megan A Murphy; Nicolas Wentzensen
Journal:  Int J Cancer       Date:  2011-04-04       Impact factor: 7.396

Review 3.  Ovarian cancer.

Authors:  Kathleen R Cho; Ie-Ming Shih
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

4.  Expression of a homeobox gene (SIX5) in borderline ovarian tumours.

Authors:  C Winchester; S Robertson; T MacLeod; K Johnson; M Thomas
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

Review 5.  Application of molecular diagnostics for the detection of Lynch syndrome.

Authors:  Maria S Pino; Daniel C Chung
Journal:  Expert Rev Mol Diagn       Date:  2010-07       Impact factor: 5.225

Review 6.  Systematic review and meta-analysis of ovarian cancers: estimation of microsatellite-high frequency and characterization of mismatch repair deficient tumor histology.

Authors:  Tuya Pal; Jenny Permuth-Wey; Ambuj Kumar; Thomas A Sellers
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

7.  Loss of DNA mismatch repair protein hMSH6 in ovarian cancer is histotype-specific.

Authors:  Qihui Jim Zhai; Daniel Gustavo Rosen; Karen Lu; Jinsong Liu
Journal:  Int J Clin Exp Pathol       Date:  2008-01-31

8.  Tumor spreading to the contralateral ovary in bilateral ovarian carcinoma is a late event in clonal evolution.

Authors:  Francesca Micci; Lisbeth Haugom; Terje Ahlquist; Vera M Abeler; Claes G Trope; Ragnhild A Lothe; Sverre Heim
Journal:  J Oncol       Date:  2009-09-15       Impact factor: 4.375

9.  Distinct high-profile methylated genes in colorectal cancer.

Authors:  Pooneh Mokarram; Krishan Kumar; Hassan Brim; Fakhraddin Naghibalhossaini; Mehdi Saberi-firoozi; Mehdi Nouraie; Robert Green; Ed Lee; Duane T Smoot; Hassan Ashktorab
Journal:  PLoS One       Date:  2009-09-11       Impact factor: 3.240

10.  Clinical significance of microsatellite instability in sporadic epithelial ovarian tumors.

Authors:  Bo-Sung Yoon; Young-Tae Kim; Jae-Hoon Kim; Sang-Wun Kim; Eun-Ji Nam; Nam-Hoon Cho; Jae-Wook Kim; Sunghoon Kim
Journal:  Yonsei Med J       Date:  2008-04-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.